- 米国企業
- Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc.CLDX
時価総額
$21.4億
PER
2011年 12月31日 | 2012年 12月31日 | 2013年 12月31日 | 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | |
Cash and cash equivalents | 12 | 25 | 169 | 28 | 72 | 42 | 40 | 24 | 11 | 44 | 39 | 29 | 35 |
Marketable securities | 41 | 59 | 134 | 173 | 218 | 147 | 99 | 70 | 53 | 151 | 369 | 276 | 389 |
Accounts and other receivables | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 3 | 1 | 2 | 0 | 0 | 3 |
Prepaid and other current assets | 1 | 1 | 2 | 4 | 4 | 4 | 3 | 2 | 1 | 2 | 2 | 12 | 5 |
Total current assets | 55 | 85 | 305 | 205 | 295 | 196 | 145 | 99 | 67 | 198 | 411 | 318 | 432 |
Property and equipment, net | 9 | 7 | 10 | 11 | 11 | 13 | 10 | 6 | 4 | 4 | 4 | 4 | 4 |
Operating Lease, Right-of-Use Asset | - | - | - | - | - | - | - | - | 3 | 3 | 3 | 4 | 3 |
Intangible assets | 25 | 24 | 23 | 22 | 21 | 81 | 68 | 49 | 49 | 31 | 27 | 27 | 27 |
Other assets | 0 | 0 | 0 | 2 | 1 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 |
Total assets | 98 | 126 | 347 | 248 | 338 | 383 | 316 | 156 | 123 | 236 | 445 | 353 | 466 |
Accounts payable | 1 | 1 | 2 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 3 | 3 |
Accrued expenses | 7 | 11 | 17 | 19 | 24 | 29 | 19 | 7 | 6 | 8 | 12 | 13 | 22 |
Operating Lease, Liability, Current | - | - | - | - | - | - | - | - | 2 | 1 | 2 | 1 | 2 |
Other Liabilities, Current | 0 | 0 | 1 | 3 | 4 | 5 | 7 | 5 | 2 | 3 | 2 | 1 | 4 |
Total current liabilities | 14 | 18 | 20 | 24 | 30 | 35 | 28 | 13 | 12 | 14 | 17 | 19 | 31 |
Operating Lease, Liability, Noncurrent | - | - | - | - | - | - | - | - | 2 | 2 | 1 | 3 | 1 |
Other long-term liabilities | 6 | 6 | 7 | 12 | 17 | 83 | 52 | 19 | 16 | 10 | 7 | 5 | 4 |
Total liabilities | 29 | 30 | 27 | 36 | 47 | 118 | 79 | 32 | 29 | 26 | 25 | 27 | 36 |
Common Stock, Value, Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Additional paid-in capital | 271 | 357 | 663 | 673 | 879 | 982 | 1,046 | 1,084 | 1,105 | 1,280 | 1,561 | 1,581 | 1,823 |
Accumulated other comprehensive income | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 1 | 3 |
Accumulated deficit | -205 | -264 | -346 | -464 | -591 | -719 | -813 | -962 | -1,013 | -1,073 | -1,144 | -1,256 | -1,397 |
Total stockholders' equity | 69 | 96 | 320 | 212 | 290 | 265 | 236 | 124 | 94 | 209 | 419 | 326 | 429 |
Total liabilities and stockholders' equity | 98 | 126 | 347 | 248 | 338 | 383 | 316 | 156 | 123 | 236 | 445 | 353 | 466 |